92 related articles for article (PubMed ID: 8479612)
1. Characterization of cysteamine induction of the 22K prolactin variant in the rat pituitary.
Anthony PK; Powers CA
Neuroendocrinology; 1993 Jan; 57(1):167-76. PubMed ID: 8479612
[TBL] [Abstract][Full Text] [Related]
2. The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release.
Anthony PK; Stoltz RA; Pucci ML; Powers CA
Endocrinology; 1993 Feb; 132(2):806-14. PubMed ID: 8425495
[TBL] [Abstract][Full Text] [Related]
3. Prolactin proteolysis by glandular kallikrein: in vitro reaction requirements and cleavage sites, and detection of processed prolactin in vivo.
Powers CA; Hatala MA
Endocrinology; 1990 Oct; 127(4):1916-27. PubMed ID: 2401236
[TBL] [Abstract][Full Text] [Related]
4. Cysteamine acts immediately to inhibit prolactin release and induce cellular changes in estradiol-primed male rats.
Saunders SL; Shin SH; Reifel CW
Neuroendocrinology; 1984 Mar; 38(3):182-8. PubMed ID: 6325979
[TBL] [Abstract][Full Text] [Related]
5. Cysteamine induces depletion of both immunological and biological prolactin activity in the anterior pituitary and blood of the rat.
Millard WJ; Sagar SM; Simpkins JW; Owens RE; Badger TM; Friesen HG; Martin JB
Endocrinology; 1983 Dec; 113(6):2161-7. PubMed ID: 6641630
[TBL] [Abstract][Full Text] [Related]
6. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
Parsons JA; Peterson EK; Hartfel MA
Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of action of cysteamine in depleting prolactin immunoreactivity.
Sagar SM; Millard WJ; Martin JB; Murchison SC
Endocrinology; 1985 Aug; 117(2):591-600. PubMed ID: 3926458
[TBL] [Abstract][Full Text] [Related]
8. Thiol regulation of depletion-transformation and release of prolactin by the pituitary of the lactating rat.
Mena F; Clapp C; Aguayo D; Lorenson MY; Martinez-Escalera G
Endocrinology; 1986 May; 118(5):1795-802. PubMed ID: 3698895
[TBL] [Abstract][Full Text] [Related]
9. Biological thiols elicit prolactin proteolysis by glandular kallikrein and permit regulation by biochemical pathways linked to redox control.
Hatala MA; DiPippo VA; Powers CA
Biochemistry; 1991 Aug; 30(31):7666-72. PubMed ID: 1868047
[TBL] [Abstract][Full Text] [Related]
10. Cysteamine-induced depletion of somatostatin and prolactin.
Millard WJ; Sagar SM; Martin JB
Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
[TBL] [Abstract][Full Text] [Related]
11. Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
Scammell JG; Burrage TG; Eisenfeld AJ; Dannies PS
Endocrinology; 1985 Jun; 116(6):2347-54. PubMed ID: 3996317
[TBL] [Abstract][Full Text] [Related]
12. The effect of cysteamine, cystamine, and the structurally related compounds taurine, N-acetyl-cysteine, and D-penicillamine on plasma prolactin levels in normal and estrogen-primed hyperprolactinemic rats.
Scott JS; Lakin CA; Oliver JR
Endocrinology; 1987 Aug; 121(2):812-8. PubMed ID: 3109888
[TBL] [Abstract][Full Text] [Related]
13. Depletion of bovine pituitary prolactin by cysteamine involves a thiol:disulfide mechanism.
Lorenson MY; Jacobs LS
Endocrinology; 1984 Oct; 115(4):1492-5. PubMed ID: 6479100
[TBL] [Abstract][Full Text] [Related]
14. Cysteamine, zinc, and thiols modify detectability of rat pituitary prolactin: a comparison with effects on bovine prolactin suggests differences in hormone storage.
Jacobs LS; Lorenson MY
Metabolism; 1986 Mar; 35(3):209-15. PubMed ID: 3081777
[TBL] [Abstract][Full Text] [Related]
15. Glandular kallikrein in estrogen-induced pituitary tumors: time course of induction and correlation with prolactin.
Hatala MA; Powers CA
Cancer Res; 1988 Aug; 48(15):4158-62. PubMed ID: 3390808
[TBL] [Abstract][Full Text] [Related]
16. Reversal by thiols of dopamine-, stalk-median eminence-, and zinc-induced inhibition of prolactin transformation in adenohypophyses of lactating rats.
Martinez-Escalera G; Clapp C; Morales MT; Lorenson MY; Mena F
Endocrinology; 1986 May; 118(5):1803-7. PubMed ID: 3698896
[TBL] [Abstract][Full Text] [Related]
17. Glandular kallikreins in the teleost Cyprinus carpio: tissue distribution, possible involvement in prolactin processing, and effect of 17 beta-estradiol in vivo.
Figueroa J; Fernández K; Haussmann D; Richards G; Barra V; Kausel G
Gen Comp Endocrinol; 2002 Sep; 128(2):135-42. PubMed ID: 12392686
[TBL] [Abstract][Full Text] [Related]
18. Cysteamine depletes prolactin (PRL) but does not alter the structure of PRL-containing granules in the anterior pituitary.
Weinstein LA; Landis DM; Sagar SM; Millard WJ; Martin JB
Endocrinology; 1984 Oct; 115(4):1543-50. PubMed ID: 6479101
[TBL] [Abstract][Full Text] [Related]
19. Effects of cysteamine on the hypothalamic-pituitary axis in the rat.
McComb DJ; Cairns PD; Kovacs K; Szabo S
Fed Proc; 1985 Jun; 44(9):2551-5. PubMed ID: 2860017
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy of cysteamine in depleting prolactin immunoreactivity in different hyperprolactinemic animal models.
Millard WJ; Romano TM
Life Sci; 1991; 49(22):1635-42. PubMed ID: 1943468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
